GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis

BACKGROUND: The last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication. Last studies suggested beneficial effects of SG...

Descripción completa

Detalles Bibliográficos
Autores principales: Grenet, Guillaume, Ribault, Shams, Nguyen, Giao Bao, Glais, Faustine, Metge, Augustin, Linet, Thomas, Kassai-Koupai, Behrouz, Cornu, Catherine, Bejan-Angoulvant, Théodora, Erpeldinger, Sylvie, Boussageon, Rémy, Gouraud, Aurore, Bonnet, Fabrice, Cucherat, Michel, Moulin, Philippe, Gueyffier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592598/
https://www.ncbi.nlm.nih.gov/pubmed/31237921
http://dx.doi.org/10.1371/journal.pone.0217701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592598/
https://www.ncbi.nlm.nih.gov/pubmed/31237921
http://dx.doi.org/10.1371/journal.pone.0217701

Ejemplares similares